Vasodilatory septic shock refractory to catecholamines: Is there a role for terlipressin?;Choc septique réfractaire aux catécholamines: Y a-t-il une place pour la terlipressine?

Annales Francaises d'Anesthesie et de Reanimation

Volumn 22, Issue 7, 2003, Pages 631-634

  Fellahi, J L ^a   Benard P ^a   Daccache, G ^a   Mourgeon, E ^a   Gerard J L ^b  

^a CAEN UNIVERSITY HOSPITAL   (France)

^b CHU CÔTE DE NACRE   (France)

Author keywords

Septic shock; Terlipressin

Indexed keywords

CATECHOLAMINE; NORADRENALIN; TERLIPRESSIN;

AGED; ARTERIAL PRESSURE; ARTICLE; CASE REPORT; CLINICAL FEATURE; DOSE RESPONSE; DRUG EFFECT; DRUG INDICATION; DRUG INFUSION; FEMALE; HEART FUNCTION; HEMODYNAMICS; HUMAN; LOW DRUG DOSE; MALE; SEPTIC SHOCK; SKIN NECROSIS; SPLANCHNIC BLOOD FLOW; SURVIVAL; SYSTEMIC VASCULAR RESISTANCE; VASOCONSTRICTION; VASODILATATION;

EID: 0042820168     PISSN: 07507658     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0750-7658(03)00218-1     Document Type: Article

References (16)

1. Parillo JE, Parker MM, Natanson C, Suffredini AF, Danner RL, Cunnion RE, et al. Septic shock in humans. Ann Intern Med 1990;113: 227-42.
2. e conférence de consensus en réanimation et médecine d'urgence. Utilisation des catécholamines au cours du choc septique. Réan Urg 1996;5:441-50.
3. Landry DW, Levin HR, Gallant EM, Seo S, D'Alessandro D, Mehmet C, et al. Vasopressin pressor hypersensitivity in vasodilatory septic shock. Crit Care Med 1997;25:1279-82.
4. Landry DW, Levin HR, Gallant EM, Ashton Jr RC, Seo S, D'Alessandro D, et al. Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation 1997;95:1122-5.
5. Dünser MW, Mayr AJ, Ulmer H, Ritsch N, Knotzer H, Pajk W, et al. The effects of vasopressin on systemic hemodynamics in catecholamine-resistant septic and postcardiotomy shock: a retrospective analysis. Anesth Analg 2001;93:7-13.
6. Patel BM, Chittock DR, Russell JA, Walley KR. Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology 2002;96:576-82.
7. Freeman JG, Cobden I, Lishman AM, Record CO. Controlled trial of terlipressin (glypressin) versus vasopressin in the early treatment of oesophageal varices. Lancet 1982;2:66-8.
8. O'Brien A, Clapp L, Singer M. Terlipressin for norepinephrine-resistant septic shock. Lancet 2002;359:1209-10.
9. Eyraud D, Brabant S, Dieudonne N, Fléron MH, Godet G, Bertrand M, et al. Treatment of intraoperative refractory hypotension with terlipressin in patients chronically treated with an antagonist of the renin-angiotensin system. Anesth Analg 1999;88:980-4.
10. Reid IA. Role of vasopressin deficiency in the vasodilation of septic shock [editorial]. Circulation 1997;95:1108-10.
11. Holmes CL, Patel BM, Russell JA, Walley KR. Physiology of vasopressin relevant to management of septic shock. Chest 2001;120:989-1002.
12. Lindner KH, Prenfel AW, Pfenninger EG. Vasopressin improves vital organ blood flow during closed-chest cardiopulmonary resuscitation in pigs. Circulation 1995;91:215-21.
13. Jardin F, Brun-Ney D, Auvert B, Beauchet A, Bourdarias JP. Sepsis-related cardiogenic shock. Crit Care Med 1990;18:1055-60.
14. Kerr JC, Reynolds DG, Swan KG. Vasopressin and blood flow to the canine intestine. J Surg Res 1978;25:35-41.
15. Holliger CH, Radzyner M, Knoblauch M. Effects of glucagon, vasoactive intestinal peptide, and vasopressin on villous microcirculation and superior mesenteric artery blood flow of the rat. Gastroenterology 1983;85:1036-43.
16. Laszlo FA, Laszlo Jr F, De Wied D. Pharmacology and clinical perspectives of vasopressin antagonists. Pharmacol Rev 1991;43:73-108.